Tag: Weill Cornell Medicine
-
Researchers Reveal a Powerful New Gene-Switch Tool
Groundbreaking Gene-Switch Technology Emerges from Weill Cornell Medicine Researchers at Weill Cornell Medicine have unveiled a versatile, non-toxic technology designed to precisely control the activity of any gene within a cell. Dubbed a “gene-switch” tool, this system enables scientists to selectively turn a target gene on or off, providing a powerful platform for understanding gene…
-
Researchers Unveil a Powerful New Gene-Switch Tool
A Breakthrough in Gene Regulation Researchers at Weill Cornell Medicine have introduced a versatile, non-toxic technology that can control the activity of any gene in a cell. Dubbed a “gene-switch” tool, this innovation promises to give scientists a reliable way to turn on or turn off a target gene, enabling deeper exploration of gene function,…
-
Weill Cornell and UM Miller Researchers Secure $4 Million to Study Economics of Substance Use Disorder Treatments
Five-Year, $4 Million NIDA Grant Aims to Decode the Economics of SUD Treatments A collaboration between Weill Cornell Medicine and the University of Miami’s Miller School of Medicine has secured a five-year, $4 million grant from the National Institute on Drug Abuse (NIDA) to advance health economics research in substance use disorder (SUD) treatment. The…
-
Researchers Awarded $4 Million to Study Economics of Substance Use Disorder Treatments
New NIDA Grant Fuels Economic Study of Treatment Options A consortium led by Weill Cornell Medicine and the University of Miami’s Miller School of Medicine has secured a five-year, $4 million grant from the National Institute on Drug Abuse (NIDA). The funding will support a comprehensive health economics study focused on the effectiveness, accessibility, and…